Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harrow Inc
(NQ:
HROW
)
42.70
+1.38 (+3.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow Inc
< Previous
1
2
3
4
5
6
7
Next >
Recap: Harrow Health Q2 Earnings
August 09, 2022
Harrow Health (NASDAQ:HROW) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Harrow Health Announces Second Quarter 2022 Financial Results
August 09, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022
July 27, 2022
From
Harrow Health, Inc.
Via
Business Wire
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Earnings Scheduled For August 10, 2021
August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...
Via
Benzinga
Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States
June 24, 2022
From
Harrow Health, Inc.
Via
Business Wire
7 Mighty Micro-Cap Stocks That Could Be Future Moonshots
May 30, 2022
These seven micro-cap stocks, either due to catalysts or a low valuation, could make a move to substantially higher prices.
Via
InvestorPlace
Harrow Health Announces First Quarter 2022 Financial Results
May 05, 2022
From
Harrow Health, Inc.
Via
Business Wire
Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation
May 04, 2022
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference
April 22, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Announce First Quarter 2022 Financial Results on May 5, 2022
April 20, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Announces Appointments to Its Board of Directors
March 31, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Announce Fourth Quarter and Year-End 2021 Financial Results on March 10, 2022
February 24, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Announces FDA Acceptance of New Drug Application for AMP-100
February 22, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Present at Aegis Virtual Conference
February 15, 2022
From
Harrow Health, Inc.
Via
Business Wire
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
Biotech insiders are among the most important investors to pay close attention to. Here are two that show good signs for the future.
Via
InvestorPlace
Harrow Health Publishes Corporate Transparency Report
February 08, 2022
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Participate in H.C. Wainwright BioConnect Conference
January 10, 2022
From
Harrow Health, Inc.
Via
Business Wire
Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA
January 04, 2022
From
Melt Pharmaceuticals, Inc.
Via
Business Wire
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
December 20, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Added to the Nasdaq Biotechnology Index
December 13, 2021
From
Harrow Health, Inc.
Via
Business Wire
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces Commercialization Agreement For Dexycu To Treat Post-...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
Harrow Health Announces Third Quarter 2021 Financial Results
November 09, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021
October 25, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals
September 02, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Acquires Japan-Approved Ophthalmic Injection For Undisclosed Sum
August 18, 2021
For an undisclosed amount, Harrow Health Inc (NASDAQ: HROW) has agreed to acquire MAQ-100 U.S. and Canadian commercial rights from Wakamoto...
Via
Benzinga
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
August 18, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health to Participate in Two Upcoming Virtual Investor Conferences
August 12, 2021
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health: Q2 Earnings Insights
August 10, 2021
Shares of Harrow Health (NASDAQ:HROW) were flat after the company reported Q2 results. Quarterly Results Earnings per share decreased 1000.00% year over year to ($0.11),...
Via
Benzinga
Harrow Health Announces Second Quarter 2021 Financial Results
August 10, 2021
From
Harrow Health, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.